Mitragyna speciosa (Rubiaceae) Common Kratom, Ketum, Thom

Mitragyna speciosa, commonly known as kratom, is a tropical evergreen tree native to Southeast Asia, particularly Thailand, Malaysia, Indonesia, and Papua New Guinea . It belongs to the Rubiaceae family, which also includes coffee and gardenia. For centuries, the leaves of this tree have been used in traditional medicine as a mild stimulant to combat fatigue and as an opium substitute to manage pain . In recent decades, kratom has gained significant global attention, being marketed as a dietary supplement for pain relief, mood enhancement, and the management of opioid withdrawal symptoms . However, its use is complex, marked by a unique pharmacology that offers both therapeutic potential and considerable safety concerns.

1. Taxonomic Insights

Species: Mitragyna speciosa (Korth.) Havil.

Family: Rubiaceae

The Rubiaceae family is one of the largest families of flowering plants, comprising trees, shrubs, and herbs. It is of immense economic importance, providing coffee (Coffea spp.), quinine (Cinchona spp.), and numerous ornamental plants. The genus Mitragyna consists of about ten species found in the tropical regions of Africa and Asia. The name is derived from the Latin word mitra, meaning "bishop's mitre," and the Greek word gynaika, meaning "woman," referring to the shape of the flower's stigma . M. speciosa is closely related to M. parvifolia, which is found in India and Sri Lanka.

Taxonomic Note: The species was first described by Pieter Willem Korthals in 1840 as Stephegyne speciosa. It was later transferred to the genus Mitragyna by George Haviland in 1897 . This species is a large tree, capable of growing up to 25 metres tall, with smooth grey bark, ovate leaves with prominent veins, and yellowish-white flowers that form in spherical heads . Interestingly, scientific studies have shown that the alkaloid profile of M. speciosa can vary significantly between individual trees, with some containing very little of the primary alkaloid mitragynine, indicating the existence of different chemotypes .

Related Herbs from the Same Family:

· Coffea arabica (Coffee): A well-known shrub that produces coffee beans. It shares the family's production of psychoactive alkaloids (caffeine) and its use as a stimulant.

· Cinchona officinalis (Cinchona): A tree native to South America, famous for its bark's quinine content, a historical treatment for malaria.

· Gardenia jasminoides (Gardenia): A popular ornamental shrub known for its fragrant white flowers. While not medicinal, it is a well-known relative.

· Uncaria tomentosa (Cat's Claw): A woody vine from South America used in traditional medicine for its anti-inflammatory and immunostimulant properties.

2. Common Names

Scientific Name: Mitragyna speciosa | English: Kratom, Ketum, Biak-biak | Thai: Kratom (กระท่อม), Thom (ท่อม) | Malay: Ketum, Biak-biak | Indonesian: Ketum, Kratom | Burmese: Bein

3. Medicinal Uses

Primary Actions: Analgesic, Stimulant, Opioid Withdrawal Management, Antidiarrheal

Secondary Actions: Anxiolytic, Antidepressant, Antipyretic, Antitussive, Antihypertensive

Medicinal Parts:

The leaves are the primary part used medicinally.

· Leaves (Fresh or Dried): In traditional Southeast Asian medicine, the leaves are chewed, smoked, or brewed into a tea to treat a variety of conditions. They are used as a stimulant to fight fatigue and improve work productivity, as a pain reliever, and to treat diarrhoea and coughs .

4. Phytochemicals Specific to the Plant and Their Action

The therapeutic and psychoactive effects of kratom are primarily due to its complex alkaloid content, of which over 40 have been identified .

· Indole and Oxindole Alkaloids: These are the major bioactive constituents, with mitragynine being the most abundant, accounting for up to 66% of the total alkaloid content .

· Mitragynine: This is the primary psychoactive alkaloid. It acts as a partial agonist at the μ-opioid receptors but with a different mechanism than classical opioids, resulting in its unusual dose-dependent effects. At low doses, it acts as a stimulant, while at higher doses, it produces opioid-like analgesia and euphoria .

· 7-Hydroxymitragynine: Though present in much smaller quantities, this alkaloid is significantly more potent than mitragynine as an analgesic and is considered the primary contributor to its opioid-like effects . It is also thought to be a metabolite of mitragynine.

· Other Notable Alkaloids: Other minor alkaloids contribute to the plant's overall effects and represent a growing area of research. For example, speciogynine has recently shown promising anti-epileptic potential in zebrafish models . The presence of flavoalkaloids was also recently reported, expanding the known chemical diversity of the plant .

5. Traditional and Ethnobotanical Uses Covering the Medicinal Uses

Fatigue and As a Stimulant

Formulation: Chewed leaves or tea.

Preparation and Use: In rural Southeast Asian communities, labourers chew kratom leaves throughout the day to combat fatigue, increase energy, and improve work endurance. This is the most traditional and well-documented use of the plant .

Reasoning: The stimulant effect is attributed to mitragynine, which at low doses acts on alpha-2 adrenergic receptors and may also affect serotonergic and dopaminergic pathways. This provides a boost of energy without the jittery side effects associated with caffeine .

Pain Relief (Analgesic)

Formulation: Leaf tea, decoction, or chewed leaves.

Preparation and Use: The leaves are traditionally used to alleviate pain and are consumed by people suffering from chronic pain, rheumatism, and injuries . This use is now one of the primary reasons for its global popularity.

Reasoning: Mitragynine and 7-hydroxymitragynine target the μ-opioid receptors in the brain, producing significant analgesic effects. Importantly, studies suggest that as biased agonists, they may offer pain relief with a lower risk of respiratory depression compared to classical opioids like morphine .

Opioid Dependence and Withdrawal

Formulation: Leaf tea or concentrated extracts.

Preparation and Use: In Southeast Asia, kratom has been used as a substitute for opium to help manage withdrawal symptoms and reduce cravings. This traditional application has led to its investigation as a potential harm-reduction tool for opioid use disorder .

Reasoning: The action of mitragynine on the μ-opioid receptors helps to mitigate the severity of withdrawal symptoms and cravings by providing a mild, long-acting opioid effect without the high risk of severe respiratory depression and euphoria associated with other opioids .

Gastrointestinal Disorders

Formulation: Leaf tea or decoction.

Preparation and Use: Kratom tea is traditionally used to treat diarrhoea, intestinal infections, and dysentery .

Reasoning: The plant's antidiarrheal effect is primarily due to its alkaloids' action on the μ-opioid receptors in the gut. This reduces intestinal motility, effectively slowing down the digestive system and providing relief from diarrhoea.

6. Healing Recipes, Decoctions, and Preparations

Kratom Tea for Energy and Mild Pain

Purpose: To stimulate and provide mild analgesia.

Preparation and Use:

1. Take a few fresh or dried kratom leaves.

2. Boil them in 500 ml of water for 15-20 minutes.

3. Strain and drink the tea slowly. Start with a small amount to assess individual tolerance.

Traditional Leaf Chew

Purpose: To combat fatigue.

Preparation and Use:

1. Take 1-2 fresh kratom leaves.

2. Remove the central vein.

3. Chew the leaves for a period of time, spitting out the fibrous residue.

Culinary Uses of Mitragyna speciosa (Kratom)

Kratom is not typically used as a food in the culinary sense. Its primary use is medicinal, with leaves consumed as tea, chewed, or processed into extracts and powders.

Foraging and Preparation Notes

Harvesting: The leaves are harvested from mature trees. They are collected year-round, with the vein colour (red, green, white) often associated with different purported effects, although scientific evidence for this classification is limited.

Sustainability: The increasing global demand for kratom has raised concerns about unsustainable harvesting practices and the potential to deplete wild populations. Sustainable cultivation is crucial for its long-term availability.

7. In-Depth Phytochemical Profile and Clinical Significance of Mitragyna speciosa (Kratom)

Introduction

Mitragyna speciosa is a plant of profound contradictions, embodying a unique and complex intersection of traditional healing and modern public health debate. Its long history of use in Southeast Asia as a stimulant and folk remedy is now being scrutinised and validated by modern science, which has uncovered a remarkable and intricate alkaloid chemistry. The plant's identity is defined by its signature alkaloid, mitragynine, which confers a biphasic pharmacological profile—acting as a stimulant at low doses and as an opioid-like analgesic at higher doses. This unique action, along with its potential as a harm-reduction tool for opioid addiction, has made it a subject of intense research and regulatory controversy worldwide .

1. Indole Alkaloids: The Biphasic Pharmacological Arm

Key Compounds: Mitragynine, 7-Hydroxymitragynine.

Quantitative Profile: Mitragynine is the principal alkaloid in the leaves, typically comprising around 66% of the total alkaloid content. 7-Hydroxymitragynine is a minor alkaloid, found in much smaller amounts (often less than 1%), but is a potent and active metabolite of mitragynine . The concentration of these alkaloids can vary significantly based on the tree's chemotype, geographic origin, and leaf maturity .

Actions and Clinical Relevance:

· Biphasic Effects (Stimulation and Analgesia): This is the defining feature of kratom's pharmacology. At low doses, mitragynine acts as a stimulant, providing energy and focus. At higher doses, its action on the μ-opioid receptors predominates, leading to pain relief and a sense of well-being, but also carries a risk of sedation and dependence .

· Opioid Withdrawal Management: The action of mitragynine as a partial μ-opioid receptor agonist makes it potentially valuable in managing opioid withdrawal. Its effects are considered "atypical" compared to full agonists, potentially offering a safer profile with lower abuse potential. This is a key area of ongoing research and clinical interest .

· Therapeutic Window and Toxicity: The clinical pharmacology reveals a narrow therapeutic window. The benefits for pain and withdrawal are dose-dependent, but as the dose increases, so does the risk of adverse effects, including nausea, constipation, and more severe risks like seizures, which have been reported at high doses .

2. Other Bioactive Compounds and Emerging Research

Key Compounds: Speciogynine, Corynantheidine, Flavoalkaloids.

Pharmacological Profile: Research is expanding beyond the two main alkaloids, revealing a rich and diverse chemical landscape with potential for new therapeutic applications. For example, a recent study identified speciogynine as a potential anti-epileptic lead compound after demonstrating significant dose-dependent effects in a zebrafish model . Additionally, the discovery of flavoalkaloids in M. speciosa adds a new class of compounds to its phytochemical repertoire .

Actions and Clinical Relevance:

· Anti-epileptic Potential: The traditional use of M. speciosa for neurological problems has been little studied, but the recent finding of speciogynine's antiepileptic activity suggests it could be a valuable source for new drug development .

· Cytotoxicity and Anticancer Potential: A 2024 review highlighted that extracts and alkaloids from M. speciosa have demonstrated potential in preclinical studies against various cancer cell lines, including neuroblastoma, leukaemia, colon, and breast cancer. However, this is early-stage research and requires further investigation .

An Integrated View of Healing, Toxicity, and Regulation

Kratom's modern use is a global phenomenon driven by a confluence of factors: the ongoing opioid crisis, the search for natural alternatives for pain and mental health, and the commercialisation of a previously obscure plant. The story of kratom is a narrative of two worlds.

· Traditional and Contemporary Use: For centuries in Southeast Asia, kratom was a "tool" for rural communities to manage fatigue and pain in their daily lives. Today, in Western countries, it is often used as a self-help tool for managing chronic pain, anxiety, depression, and opioid use disorder .

· The Dual Nature (Benefits vs. Risks): The plant's therapeutic potential is real and has been validated by science, primarily for pain relief and opioid withdrawal mitigation. However, this potential is counterbalanced by significant and well-documented risks. These include dependence, withdrawal symptoms upon cessation, and serious adverse events like seizures, liver toxicity, and rare fatalities .

· The Critical Role of Product Quality: A major public health concern is the lack of regulation and standardisation of kratom products. In many countries, products are sold as unregulated dietary supplements, leading to significant variability in potency, contamination, and even adulteration with other substances .

Toxicological Profile and Quality Control

Safety Profile: Kratom is not a benign substance. It has a clear potential for abuse, dependence, and serious toxicity, particularly with high doses, prolonged use, or concurrent use of other substances . Reported adverse effects include nausea, vomiting, constipation, sweating, dry mouth, increased urination, and loss of appetite . More severe effects can include tachycardia (rapid heart rate), high blood pressure, seizures, and liver toxicity . It is crucial to recognise that reported fatalities often involve adulterated products or the co-ingestion of other drugs, but the potential for serious harm is established.

Quality Control Parameters: The variation in chemotypes and the widespread adulteration of commercial products make quality control a paramount challenge. Standardisation based on the quantification of key alkaloids like mitragynine and 7-hydroxymitragynine is essential for ensuring safety and product consistency. However, this is currently lacking in most markets.

Conclusion: Mitragyna speciosa is a plant that occupies a unique and challenging position in the modern world. Its traditional use as a stimulant and folk remedy is grounded in a sophisticated pharmacology that offers genuine therapeutic potential for pain and opioid dependence. However, this same pharmacology carries significant risks, and the unregulated nature of the kratom market poses a serious public health challenge. The plant stands as a powerful example of the need for a balanced, evidence-based approach that respects traditional knowledge while rigorously addressing safety, dependence, and quality control. The future of kratom will likely be determined by the ongoing scientific and regulatory debate, striving to harness its potential while protecting public health .

Disclaimer:

Mitragyna speciosa (kratom) is a potent psychoactive substance with a significant risk of adverse effects, dependence, and withdrawal. The US Food and Drug Administration (FDA) has not approved kratom for any medical use. Its legal status is regulated in many countries and states. This information is for educational use only and is not a substitute for professional medical advice. Do not use kratom without consulting a qualified healthcare professional, especially if you are on any medications or have pre-existing health conditions. Pregnant or nursing women should not use kratom. Seek immediate medical attention if you experience severe adverse effects.

8. Reference Books, Books for In-depth Study

· "Pharmacology of Kratom: An Emerging Botanical Agent with Stimulant, Analgesic and Opioid-like Effects" - for foundational pharmacology .

· "Clinical Pharmacology of the Dietary Supplement Kratom (Mitragyna speciosa)" (2022) - for a comprehensive clinical review .

· "Kratom (Mitragyna speciosa Korth.): ethnopharmacology, phytochemistry, therapeutic potential, and regulatory perspectives" (2026) - for an up-to-date multidisciplinary review .

· Journal of Ethnopharmacology - for traditional use studies.

· Drug and Alcohol Dependence - for dependence and withdrawal studies.

· Journal of Medical Toxicology - for toxicology and case reports.

9. Further Study: Plants That Might Interest You Due to Similar Medicinal Properties

1. Papaver somniferum (Opium Poppy)

· Species: Papaver somniferum | Family: Papaveraceae

· Similarities: The source of classical opioid analgesics like morphine and codeine. Kratom has often been compared to this plant due to its use as an analgesic and opium substitute.

2. Erythroxylum coca (Coca)

· Species: Erythroxylum coca | Family: Erythroxylaceae

· Similarities: A plant whose leaves are traditionally chewed as a stimulant to combat fatigue and altitude sickness. Its alkaloid, cocaine, is a potent stimulant, mirroring the stimulant effects of kratom at low doses.

3. Salvia divinorum (Diviner's Sage)

· Species: Salvia divinorum | Family: Lamiaceae

· Similarities: A potent psychoactive plant used in traditional Mazatec ceremonies. It has gained notoriety as a "legal high" and is a subject of similar regulatory scrutiny.

4. Tabernanthe iboga (Iboga)

· Species: Tabernanthe iboga | Family: Apocynaceae

· Similarities: A West African plant whose alkaloid, ibogaine, has been used to treat addiction to opioids and other drugs. It shares kratom's complex pharmacology and controversial status as a potential addiction treatment.

-x-xEnd-x-x